Hims Q1 Earnings: Revenue Surges 111% to $586M, Hits 2.4M Subscribers
Hims & Hers Health (NYSE: HIMS) reported exceptional Q1 2025 financial results, with revenue surging 111% year-over-year to $586.0 million. The company achieved net income of $49.5 million and Adjusted EBITDA of $91.1 million. Subscriber base grew 38% YoY to 2.4 million, with monthly online revenue per average subscriber increasing 53% to $84.
The company maintained its 2025 revenue guidance of $2.3-2.4 billion and raised Adjusted EBITDA guidance to $295-335 million. Notably, Hims & Hers introduced ambitious 2030 targets of at least $6.5 billion in revenue and $1.3 billion in Adjusted EBITDA. For Q2 2025, the company expects revenue of $530-550 million and Adjusted EBITDA of $65-75 million.
Hims & Hers Health (NYSE: HIMS) ha riportato risultati finanziari eccezionali per il primo trimestre del 2025, con ricavi in crescita del 111% su base annua, raggiungendo i 586,0 milioni di dollari. L'azienda ha registrato un utile netto di 49,5 milioni di dollari e un EBITDA rettificato di 91,1 milioni di dollari. La base di abbonati è aumentata del 38% su base annua, arrivando a 2,4 milioni, con un ricavo mensile online per abbonato medio in crescita del 53%, pari a 84 dollari.
L'azienda ha confermato le previsioni di fatturato per il 2025 tra 2,3 e 2,4 miliardi di dollari e ha rivisto al rialzo le stime dell'EBITDA rettificato, portandole tra 295 e 335 milioni di dollari. Di particolare rilievo, Hims & Hers ha presentato ambiziosi obiettivi per il 2030 che prevedono almeno 6,5 miliardi di dollari di ricavi e 1,3 miliardi di dollari di EBITDA rettificato. Per il secondo trimestre del 2025, la società prevede ricavi compresi tra 530 e 550 milioni di dollari e un EBITDA rettificato tra 65 e 75 milioni di dollari.
Hims & Hers Health (NYSE: HIMS) reportó resultados financieros excepcionales en el primer trimestre de 2025, con ingresos que aumentaron un 111% interanual hasta 586,0 millones de dólares. La compañía alcanzó un ingreso neto de 49,5 millones de dólares y un EBITDA ajustado de 91,1 millones de dólares. La base de suscriptores creció un 38% interanual hasta 2,4 millones, con ingresos mensuales en línea por suscriptor promedio que aumentaron un 53%, llegando a 84 dólares.
La empresa mantuvo su guía de ingresos para 2025 entre 2,3 y 2,4 mil millones de dólares y elevó la previsión de EBITDA ajustado a entre 295 y 335 millones de dólares. Destaca que Hims & Hers presentó ambiciosos objetivos para 2030 de al menos 6,5 mil millones de dólares en ingresos y 1,3 mil millones de dólares en EBITDA ajustado. Para el segundo trimestre de 2025, la compañía espera ingresos de 530 a 550 millones de dólares y un EBITDA ajustado de 65 a 75 millones de dólares.
Hims & Hers Health (NYSE: HIMS)는 2025년 1분기에 탁월한 재무 실적을 보고했으며, 매출이 전년 대비 111% 증가하여 5억 8,600만 달러를 기록했습니다. 회사는 순이익 4,950만 달러와 조정 EBITDA 9,110만 달러를 달성했습니다. 구독자 수는 전년 대비 38% 증가하여 240만 명에 이르렀으며, 평균 구독자 당 월간 온라인 수익은 53% 증가하여 84달러를 기록했습니다.
회사는 2025년 매출 가이던스를 23억~24억 달러로 유지하고 조정 EBITDA 가이던스를 2억 9,500만~3억 3,500만 달러로 상향 조정했습니다. 특히 Hims & Hers는 2030년 목표로 최소 65억 달러 매출과 13억 달러 조정 EBITDA를 제시했습니다. 2025년 2분기에는 매출 5억 3,000만~5억 5,000만 달러, 조정 EBITDA 6,500만~7,500만 달러를 예상하고 있습니다.
Hims & Hers Health (NYSE: HIMS) a publié des résultats financiers exceptionnels pour le premier trimestre 2025, avec un chiffre d'affaires en hausse de 111% en glissement annuel à 586,0 millions de dollars. La société a réalisé un bénéfice net de 49,5 millions de dollars et un EBITDA ajusté de 91,1 millions de dollars. La base d'abonnés a augmenté de 38% en un an pour atteindre 2,4 millions, avec un revenu mensuel en ligne par abonné moyen en hausse de 53% à 84 dollars.
L'entreprise a maintenu ses prévisions de chiffre d'affaires pour 2025 entre 2,3 et 2,4 milliards de dollars et a relevé ses prévisions d'EBITDA ajusté à 295-335 millions de dollars. Fait notable, Hims & Hers a présenté des objectifs ambitieux pour 2030 d'au moins 6,5 milliards de dollars de chiffre d'affaires et 1,3 milliard de dollars d'EBITDA ajusté. Pour le deuxième trimestre 2025, la société prévoit un chiffre d'affaires de 530 à 550 millions de dollars et un EBITDA ajusté de 65 à 75 millions de dollars.
Hims & Hers Health (NYSE: HIMS) meldete herausragende Finanzergebnisse für das erste Quartal 2025, mit einem Umsatzanstieg von 111% im Jahresvergleich auf 586,0 Millionen US-Dollar. Das Unternehmen erzielte einen Nettogewinn von 49,5 Millionen US-Dollar und ein bereinigtes EBITDA von 91,1 Millionen US-Dollar. Die Abonnentenzahl wuchs um 38% im Jahresvergleich auf 2,4 Millionen, wobei der monatliche Online-Umsatz pro durchschnittlichem Abonnenten um 53% auf 84 US-Dollar stieg.
Das Unternehmen bestätigte seine Umsatzprognose für 2025 von 2,3 bis 2,4 Milliarden US-Dollar und hob die Prognose für das bereinigte EBITDA auf 295 bis 335 Millionen US-Dollar an. Bemerkenswert ist, dass Hims & Hers ehrgeizige Ziele für 2030 vorstellte, mit mindestens 6,5 Milliarden US-Dollar Umsatz und 1,3 Milliarden US-Dollar bereinigtem EBITDA. Für das zweite Quartal 2025 erwartet das Unternehmen einen Umsatz von 530 bis 550 Millionen US-Dollar und ein bereinigtes EBITDA von 65 bis 75 Millionen US-Dollar.
- Revenue grew 111% YoY to $586.0 million in Q1 2025
- Net income increased to $49.5 million from $11.1 million YoY
- Adjusted EBITDA grew to $91.1 million from $32.3 million YoY
- Subscriber base expanded 38% to 2.4 million
- Monthly online revenue per subscriber increased 53% to $84
- Strong cash flow with $109.1 million from operations
- Raised 2025 Adjusted EBITDA guidance
- Gross margin declined to 73% from 82% YoY
- Wholesale revenue decreased 7% YoY to $9.6 million
Insights
Hims & Hers delivered exceptional Q1 with 111% revenue growth, boosted profit guidance, and set ambitious 2030 targets amid expanding personalization strategy.
Hims & Hers Health has delivered remarkable Q1 2025 results, with revenue soaring
The company has achieved substantial profitability milestones with net income of
Their online revenue surged
For Q2 2025, management projects revenue of
The introduction of ambitious 2030 targets—at least
Of their 2.4 million subscribers, 1.4 million are utilizing personalized solutions, indicating successful adoption of their more advanced offerings. The CEO's comments suggest a strategic vision for broader industry collaboration with pharmaceutical companies, diagnostic testing providers, and healthcare providers to strengthen their ecosystem and reach tens of millions of people.
Hims & Hers Reports Explosive 111% Revenue Growth in Q1 2025, Introduces Ambitious 2030 Targets
Digital health platform Hims & Hers Health, Inc. (NYSE: HIMS) reported substantial first-quarter growth with revenue more than doubling year-over-year, while also unveiling ambitious long-term financial targets that signal the company's confidence in its business model.
The telehealth provider generated
Subscriber Growth and Revenue Metrics
Hims & Hers reported its subscriber base grew to 2.4 million, a
The revenue breakdown revealed that online business continues to be the primary growth driver:
- Online Revenue:
$576.4 million 115% year-over-year - Wholesale Revenue:
$9.6 million 7% year-over-year
While gross margin decreased to
Cash Flow Strengthens
The company's operating cash flow demonstrated significant improvement, with net cash provided by operating activities reaching
Strategic Direction and Leadership Commentary
"We're starting 2025 with incredible momentum. Millions of people are turning to us for access to care that is personal, affordable, and has the potential to drive better outcomes," said Andrew Dudum, co-founder and CEO of Hims & Hers, in the release. Dudum emphasized the company's platform approach, noting expectations for "wider collaboration across the industry" including pharmaceutical players, diagnostic companies, and healthcare providers.
Chief Financial Officer Yemi Okupe highlighted that over 1.4 million subscribers are now utilizing personalized solutions. Okupe outlined the company's five-pronged growth strategy focused on "deepening personalization, expanding into new specialties, elevating the subscriber experience with access to high quality follow up care, forging innovative partnerships, and entering new geographies."
Outlook and Long-Term Targets
For the second quarter of 2025, Hims & Hers expects:
- Revenue between
$530 million $550 million - Adjusted EBITDA between
$65 million $75 million 12% to14% )
The company affirmed its full-year 2025 revenue guidance of
In a significant move that demonstrates long-term confidence, Hims & Hers introduced 2030 financial targets, including:
- Revenue of at least
$6.5 billion - Adjusted EBITDA of at least
$1.3 billion
These targets, if achieved, would represent more than 10x revenue growth from 2022 levels, showcasing the company's aggressive growth ambitions in the expanding telehealth sector.
About Adjusted Financial Measures
The company uses several non-GAAP financial measures in its reporting. Adjusted EBITDA excludes certain components that affect net income under U.S. generally accepted accounting principles (GAAP). Free Cash Flow represents operating cash flow minus capital expenditures. The company notes that it has not reconciled forward-looking Adjusted EBITDA to its most directly comparable GAAP measure due to the uncertainty of some components of the reconciliation.
This article is based solely on information provided in Hims & Hers Health, Inc.'s press release dated May 5, 2025. The content is for informational purposes only and does not constitute financial, investment, legal, or tax advice. Stock Titan and its writers make no representations as to the accuracy, completeness, or timeliness of the information. Investors should conduct their own due diligence before making any investment decisions.
Source: Hims & Hers Health, Inc.
FAQ
What was Hims & Hers (HIMS) revenue growth in Q1 2025?
How many subscribers does Hims & Hers (HIMS) have in 2025?
What are Hims & Hers (HIMS) 2030 financial targets?
What is Hims & Hers (HIMS) revenue guidance for 2025?
How much profit did Hims & Hers (HIMS) make in Q1 2025?
